These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5087047)

  • 1. Isolation and some properties of the heparin-neutralizing factor (PF4) released from human blood platelets.
    Käser-Glanzmann R; Jakábová M; Lüscher EF
    Experientia; 1972 Oct; 28(10):1221-3. PubMed ID: 5087047
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet heparin-neutralizing factor (platelet factor 4).
    Lüscher EF; Käser-Glanzman R
    Thromb Diath Haemorrh; 1975 Feb; 33(1):66-72. PubMed ID: 1091019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of heparin by cellular blood elements.
    Zuckerman L; Ramstack JM; Vagher JP; Caprini JA; Mockros LF
    Thromb Res; 1975 Jul; 7(1):149-59. PubMed ID: 1154333
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiheparin activity of human serum and platelet factor 4.
    Sear CH; Poller L
    Thromb Diath Haemorrh; 1973 Sep; 30(1):93-105. PubMed ID: 4806356
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets.
    Barber AJ; Käser-Glanzmann R; Jakábová M; Lüscher EF
    Biochim Biophys Acta; 1972 Dec; 286(2):312-29. PubMed ID: 4267228
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet-derived heparin neutralizing proteins.
    Lane DA
    Adv Exp Med Biol; 1985; 192():427-38. PubMed ID: 2939696
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcellular localization of the heparin-neutralizing factor in blood platelets.
    Da Prada M; Jakábová M; Lüscher EF; Pletscher A; Richards JG
    J Physiol; 1976 May; 257(2):495-502. PubMed ID: 950602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):370-84. PubMed ID: 1122293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of platelet factor 4 in plasma.
    Fuster V; Kazmier FJ; Cash JD; Bowie EJ; Owen CA
    Mayo Clin Proc; 1973 Feb; 48(2):103-6. PubMed ID: 4689655
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurement of the liberation of platelet factor 4 (PF4) in congenital and acquired thrombopathies].
    Kubisz P; Sultan Y; Delobel J; Caen J
    Rev Eur Etud Clin Biol; 1970; 15(6):698-704. PubMed ID: 5273147
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of antiheparin activity of serum and platelet factor 4.
    Sear CH; Poller L
    J Clin Pathol; 1972 Nov; 25(11):1007. PubMed ID: 4648526
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood platelets & heparin].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1957 Jul; 111(2):155-66. PubMed ID: 13459501
    [No Abstract]   [Full Text] [Related]  

  • 13. A COMPARISON OF THE EFFECT OF PLATELETS AND ERYTHROCYTES ON THE INHIBITORY ACTION OF BLOOD COAGULATION BY POLYBRENE AND HEPARIN.
    SHANBERGE JN; FURUTA S
    Thromb Diath Haemorrh; 1964 Oct; 12():137-47. PubMed ID: 14224630
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: The identification of two platelet specific release products.
    Moore S; Pepper DS
    Br J Haematol; 1974 Jun; 27(2):365-6. PubMed ID: 4135746
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.
    Sandberg H; Andersson LO; Höglund S
    Biochem J; 1982 Apr; 203(1):303-11. PubMed ID: 7103943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of human platelet antiheparin proteins.
    Fukami MH; Niewiarowski S; Rucinski B; Salganicoff L
    Thromb Res; 1979; 14(2-3):433-43. PubMed ID: 442016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.